Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.

Aggarwal, Rahul

Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies. [electronic resource] - Cancer chemotherapy and pharmacology Aug 2014 - 359-65 p. digital

Publication Type: Journal Article

1432-0843

10.1007/s00280-014-2510-0 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--metabolism
Blood Glucose--analysis
Female
Follow-Up Studies
Glycated Hemoglobin--metabolism
Humans
Insulin--metabolism
Male
Middle Aged
Neoplasms--drug therapy
Phosphoinositide-3 Kinase Inhibitors
Prognosis
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Retrospective Studies
Signal Transduction--drug effects
TOR Serine-Threonine Kinases--antagonists & inhibitors